A randomised trial comparing preoperative to perioperative chemotherapy in early-stage non-small-cell lung cancer (IFCT 0002 trial)

European Journal of Cancer

Volumn 49, Issue 12, 2013, Pages 2654-2664

  Westeel, Virginie ^a   Quoix, Elisabeth ^b   Puyraveau, Marc ^c   Lavole A ^d   Braun, Denis ^e   Laporte, Silvy ^f   Bigay Game, Laurence ^g   Pujol, Jean Louis ^h   Ozenne, Gervais ⁱ   Rivière, Alain ^j   Douillard, Jean Yves ^j   Lebeau, Bernard ^k   Debieuvre, Didier ^l   Poudenx, Michel ^m   David, Philippe ⁿ   Molinier, Olivier ^o   Zalcman, Gérard ^p   Lemarié, Etienne ^q   Morin, Franck ^r   Depierre, Alain ^a   Milleron, Bernard ^d   more..

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^c Centre Hospitalier Régional Universitaire de Besançon   (France)

^d HÔPITAL TENON   (France)

^e Centre Hospitalier General Maillot   (France)

^f UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^g TOULOUSE UNIVERSITY HOSPITAL   (France)

^h MONTPELLIER UNIVERSITY HOSPITAL   (France)

ⁱ Clinique du Cèdre   (France)

^j Centre de Lutte Contre le Cancer   (France)

^k HÔPITAL SAINT ANTOINE   (France)

^l Centre Hospitalier Intercommunal de Vesoul   (France)

^m UNIVERSITY HOSPITAL OF NICE   (France)

ⁿ Centre Hospitalier Intercommunal d'Elbeuf   (France)

^o Centre Hospitalier Général du Mans   (France)

^p CAEN UNIVERSITY HOSPITAL   (France)

^q UNIVERSITY HOSPITAL OF TOURS   (France)

^r NONE   (France)

more..

Author keywords

Adjuvant chemotherapy; Early stage; Neo adjuvant chemotherapy; Non small cell lung cancer; Randomised trial

Indexed keywords

CARBOPLATIN; CISPLATIN; GEMCITABINE; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG DOSE REDUCTION; DRUG SAFETY; FEMALE; HAZARD RATIO; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NEUROPATHY; PERIOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SURGICAL MORTALITY; THORACOTOMY; THROMBOCYTOPENIA; VOMITING;

ADJUVANT CHEMOTHERAPY; EARLY-STAGE; NEO-ADJUVANT CHEMOTHERAPY; NON-SMALL-CELL LUNG CANCER; RANDOMISED TRIAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NAUSEA; NEOPLASM STAGING; NEUTROPENIA; PACLITAXEL; PERIOPERATIVE CARE; PREOPERATIVE CARE; QUALITY OF LIFE; TREATMENT OUTCOME; VOMITING;

EID: 84879986951     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.04.013     Document Type: Article

References (24)

1. C.F. Mountain Revisions in the international system for staging lung cancer Chest 111 1997 1710 1717
2. R. Rosell, J. Gómez-Codina, and C. Camps A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer N Engl J Med 330 1994 153 158
3. R. Rosell, J. Gómez-Codina, and C. Camps Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial Lung Cancer 26 1999 7 14
4. J.A. Roth, F. Fossella, and R. Komaki A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer J Natl Cancer Inst 86 1994 673 680
5. J.A. Roth, E.N. Atkinson, and F. Fossella Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer Lung Cancer 21 1998 1 6
6. A. Depierre, B. Milleron, and D. Moro-Sibilot Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer J Clin Oncol 20 2002 247 253
7. K.M.W. Pisters, E. Vallières, and J.J. Crowley Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial J Clin Oncol 28 2010 1843 1849
8. G.V. Scagliotti, U. Pastorino, and J.F. Vansteenkiste Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer J Clin Oncol 30 2012 172 178
9. D. Gilligan, M. Nicolson, and I. Smith Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review Lancet 369 2007 1929 1937
10. J.L. Breton, V. Westeel, and B. Milleron Postoperative morbidity and mortality after neoadjuvant chemotherapy (NCT) for non-small cell lung cancer (NSCLC) in the French phase III trial Proc Am Soc Clin Oncol 20 2001 311a
11. A.B. Miller, B. Hoogstraten, M. Staquet, and A. Winkler Reporting results of cancer treatment Cancer 47 1981 207 214
12. W. Hryniuk, and M.N. Levine Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer J Clin Oncol 4 1986 1162 1170
13. E. Felip, R. Rosell, and J.A. Maestre Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small-cell lung cancer J Clin Oncol 28 2010 3138 3145
14. S. Burdett, L.A. Stewart, and L. Rydzewska A systematic review and meta-analysis of the literature: chemotherapy and surgery versus surgery alone in non-small cell lung cancer J Thorac Oncol 1 2006 611 621
15. T. Berghmans, M. Paesmans, and A.P. Meert Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature Lung Cancer 49 2005 13 23
16. S. Burdett, L. Rydzewska, J.F. Tierney, and J.-P. Pignon Pre-operative chemotherapy improves survival and reduces recurrence in operable non-small cell lung cancer (NSCLC). Preliminary results of a systematic review and meta-analysis of individual patient data from 13 randomised trials J Thorac Oncol 6 2011 374 375
17. R. Arriagada, A. Auperin, and S. Burdett Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data Lancet 375 2010 1267 1277
18. E. Lim, G. Harris, A. Patel, I. Adachi, L. Edmonds, and F. Song Preoperative versus postoperative chemotherapy in patients with resectable non-small cell lung cancer: systematic review and indirect comparison meta-analysis of randomized trials J Thorac Oncol 4 2009 1380 1388
19. R. Arriagada, B. Bergman, A. Dunant, T. Le Chevalier, J.-P. Pignon, and J. Vansteenkiste Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N Engl J Med 350 2004 351 360
20. J.-Y. Douillard, R. Rosell, and M. De Lena Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial Lancet Oncol 7 2006 719 727
21. T. Winton, R. Livingston, and D. Johnson Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer N Engl J Med 352 2005 2589 2597
22. J.-P. Pignon, H. Tribodet, and G.V. Scagliotti Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group J Clin Oncol 26 2008 3552 3559
23. C.A. Butts, K. Ding, and L. Seymour Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10 J Clin Oncol 28 2010 29 34
24. K.A. Olaussen, A. Dunant, and P. Fouret DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy N Engl J Med 355 2006 983 991